CIBC Private Wealth Group
IMNM icon

CIBC Private Wealth Group’s Immunome IMNM Stock Holding History

CIBC Private Wealth Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$687 Hold
32
– – ﹤0.01% 2982
2025
Q3 		$375 Hold
32
– – ﹤0.01% 2904
2025
Q2 		$298 Buy
+32
New +$262 ﹤0.01% 2880

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

CIBC Private Wealth Group's IMNM Position: Q4 2025 in Review

CIBC Private Wealth Group held its Immunome (IMNM) position steady in Q4 2025 at 32 shares worth $687. The position accounts for ﹤0.01% of the portfolio, ranked #2982.

CIBC Private Wealth Group first reported a position in IMNM in Q2 2025 and has held it in 3 quarters since. 182 funds tracked by Wall St. Rank hold IMNM as of Q4 2025.

  • CIBC Private Wealth Group held 32 shares of Immunome worth $687 as of Q4 2025.
  • CIBC Private Wealth Group left its Immunome share count unchanged in Q4 2025.
  • Immunome made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2982 holding.
  • CIBC Private Wealth Group first reported a position in Immunome in Q2 2025 and has held it in 3 quarters since.
  • 182 funds tracked by Wall St. Rank held Immunome as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.